Bringing life-changing therapies to patients in Europe
Our key services
Leading our partners to connect patients to life-changing therapies faster – with integrated solutions that drive access, efficiency and better outcomes across Europe.
End-to-end dispense and delivery
Safe, compliant, pan-European logistics – from import and title to last-mile delivery and order-to-cash.
- Supply chain management
- Pharmaceutical storage and distribution
- Purchasing and cash collection
- Dispense and delivery
- Packaging and labelling
Treatment delivery and ongoing engagement
Specialist nurses and digital tools supporting patients at home – improving adherence, persistence and outcomes.
- Digital solutions
- Patient support programmes
- Nursing and clinical services
- Clinical homecare
Market access support
Navigate Europe’s complex regulatory, pricing and reimbursement systems to bring therapies to patients faster.
Clinical study support and real-world evidence
Extend study reach, capture real-world insights and generate the evidence needed for strategic decision-making.
Cancer services
We provide at-home cancer care for 4,000 patients each year, delivering over 400 SACT regimens through our specialist nurses and dedicated compounding unit.
Health system efficiencies
Relieving NHS and health system capacity pressures through homecare services, digital tools and innovative ways to support clinical teams.
Expertise across therapeutic areas
With a deep understanding of chronic conditions, rare and speciality diseases and cancer, we combine breadth of expertise with bespoke solutions to handle even the most complex therapeutic needs.
Cancer
We provide at-home cancer care for 4,000 patients each year, delivering over 400 SACT regimens through our specialist nurses and dedicated compounding unit.
Chronic conditions
We support 300,000 patients each year with digitally-enabled, clinician-led care for complex and chronic conditions, improving adherence by over 10% and generating real-world insights across 70 therapy areas.
Rare and speciality diseases
We provide access to rare and speciality medicines across Europe, supplying 300,000 units annually to over 4,000 hospitals and pharmacies, with $400m of orphan drugs traded each year.
Are you a patient?
Visit our patient hub for support, guidance, resources and more.
Who we help
We work closely with all business and healthcare stakeholders to unlock European markets faster, improve outcomes for patients and deliver real-world evidence for rapid, smarter decision-making.
Biopharma
Whether you’re launching a new therapy, scaling market access across Europe or supporting real-world evidence generation, Sciensus delivers the infrastructure, expertise and digital capability to help you reach the right patients at the right time with the right support.
Health systems
Our holistic end-to-end service creates capacity in overburdened systems through reliable and efficient medication dispensing, digitally enabled clinician-led care and engaging patient support programmes that improve adherence and overall health outcomes.
CROs and CCOs
We can partner to expand capabilities, unlock new geographies and provide additional capacity across the drug development lifecycle – from non-interventional trials to launch planning, early access programmes and pan-European distribution.
Expertise that makes the difference
With our clinical expertise, 30 years’ experience and insights from over 70m interactions, no one knows patients like we do.
$ 0
worth of drugs distributed each year
0
patients supported each year
0
hospital, clinic & pharmacy partners
0
therapy areas
-
European operations network: the fastest route to patients
-
Patient engagement: care that drives outcomes
-
Evidence generation: insight grounded in lived experience
News and Insights
Stay up to date with the news and learn from our experts across Sciensus.
